FundedIQ
Artificial Intelligence

Interos

Interos is a provider of supply chain risk management solutions using artificial intelligence and software-as-a-service models for both the US government and private companies. The main focus of Interos' offerings involves collecting and analyzing large data sets to identify connections, patterns, and correlations. The goal is to provide customers with predictive and prescriptive insights to evaluate, oversee, and strengthen the resilience of their business networks while mitigating risks. Since business networks consist of supply chains, partnerships, and alliances, any changes in these relationships can bring about unforeseen risks and ripple effects. Interos' platform offers various tools such as Eco-system Maps, Supplier Risk Assessments, Scoring, and Continuous Monitoring. Established in 2005, Interos is headquartered in Arlington, Virginia.

www.interos.ai Arlington, United States 251-500 employees
Total raised
$180M
Latest round: +12% of prior total
Rounds
6
Latest
Series Unknown
Jan 2026

Interos is a provider of supply chain risk management solutions using artificial intelligence and software-as-a-service models for both the US government and private companies. The main focus of Interos' offerings involves collecting and analyzing large data sets to identify connections, patterns, and correlations. The goal is to provide customers with predictive and prescriptive insights to evaluate, oversee, and strengthen the resilience of their business networks while mitigating risks. Since business networks consist of supply chains, partnerships, and alliances, any changes in these relationships can bring about unforeseen risks and ripple effects. Interos' platform offers various tools such as Eco-system Maps, Supplier Risk Assessments, Scoring, and Continuous Monitoring. Established in 2005, Interos is headquartered in Arlington, Virginia.

Interos has raised $180M across 6 rounds. Its most recent round was a Series Unknown of $20.0M in Jan 2026. Full funding history, investors, and team are detailed below.

Funding history

6 rounds · 1 visible Unlock with plan

6 rounds on record — latest round shown, the rest unlock with a paid plan.

Date
Round
Amount
Lead investor
Jan 6, 2026
Series Unknown
$20.0M

Unlock 5 earlier rounds — dates, amounts, round types — plus the lead investor for every round.

Unlock funding history →

People

Unlock with plan

Founders, executives, and decision-makers — sourced and refreshed weekly.

Name
Role
LinkedIn

See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.

Unlock people data →

Interos is featured in

Similar companies

Xellar Biosystems

Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment.

Series A $29.5M
Taxwire

Global Sales Tax Compliance Software

Series A $25.0M
Derya

Derya is an AI-native freight-forwarding/logistics software company that provides an AI workbench for freight forwarders and related content.

Seed $1.1M
TIFIN

TIFIN is a platform that conceives, creates, and operates fintech companies in the areas of wealth management, investments, and personal finance. Their operating companies are shaping the future of investor experience with intelligent products that recognize the uniqueness of each investor. TIFIN leverages the combined power of investment intelligence, data science, and technology to make investing a more powerful driver of financial well-being.

Series Unknown
Proception
Seed $11.0M
8090 Solutions

8090 Solutions provides an AI-native software development platform through Software Factory, a system designed to help teams manage the software development lifecycle from planning to deployment. The platform connects business requirements, architecture planning, implementation tasks, testing, and feedback within a shared workspace using AI-driven workflows and knowledge management. 8090 Solutions enables organizations to coordinate product, engineering, and business teams while maintaining visibility across software projects. The company’s solutions support custom software development, AI-assisted engineering processes, and enterprise software delivery through structured collaboration between teams and AI agents.

Series A $135M
Baz

Developers no longer have to manually piece together the impact of pull requests; Baz models, analyzes and reviews code changes, detecting breaking changes, enforcing consistency, and highlighting misaligned coding patterns. Baz makes every review faster, more accurate, and aligned with the real-world impact of the code changes being made.

Seed $9.0M
Eccentric Machines

Eccentric Machines is a manufacturer of robotic actuator technology enabling advanced motion control for embodied AI systems.

Seed $5.0M
EIS Automation

EIS Automation provides modular automation and robotic solutions for manufacturing.

Series Unknown $2.0M
Pocket

Pocket is a technology company that develops an AI-enabled note-taking system combining a dedicated recording device with companion software. Its platform records in-person conversations and phone calls, transcribes audio, and organizes the content into searchable transcripts, summaries, action items, and mind maps. The system supports offline recording, cloud synchronization, and access across mobile, desktop, and web applications, with support for more than 120 languages. Pocket also provides AI-powered features for organizing, searching, and exporting recorded information while offering integrations with task management workflows. Its products are designed for individuals and teams who need to capture, organize, and retrieve information from conversations and spoken ideas.

Seed $11.0M
Straiker

Straiker builds AI-native security solutions tp protect customers from a spectrum of security & safety risks.

Series A $64.0M
Engine Biosciences

Engine Biosciences is a biotech company that uses machine learning to study genomics for the purpose of drug discovery. They are a technology company based in both San Francisco and Asia that is funded by investors. They specialize in network biomedicine and have developed their own patented technologies that involve extensive laboratory experimentation and artificial intelligence algorithms. These technologies are used for both drug discovery and cellular reprogramming. The company's research and development platform, which was created by a team of esteemed scientists and professors from universities such as MIT and Harvard, significantly speeds up and reduces the cost of developing new medical treatments. Engine Biosciences actively utilizes this platform internally and collaborates with partners in various disease areas.

Series Unknown
Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.